Immuron’s commercially available products found to neutralise COVID-19 during in vitro research

Biopharmaceutical company Immuron (ASX: IMC) has revealed the IMM-124E, which is used in its commercially available Travelan product, has demonstrated neutralising activity against COVID-19.

This category is empty! Please try another category or use our search function to find what you are looking for. If you require further assistance please contact us.